Flowserve Corporation heads into its July 29 earnings date with a fresh downgrade landing today and short interest that has nearly doubled in six weeks.
The most immediate development is an analyst reversal filed this morning. TD Cowen cut FLS from Buy to Hold and dropped its price target from $85 to $70 — a 17-point move that puts the firm's target 12% below the current price of $79.98. That's a meaningful shift in tone. The broader analyst community has not followed suit: six of ten covering analysts still rate the stock a Buy or equivalent, and the consensus mean target is $88.50, roughly 11% above current levels. RBC Capital trimmed its target to $91 from $98 in early May while keeping its Outperform, and a handful of others have made minor cuts since April earnings. The direction of travel is cautious trimming rather than capitulation — but TD Cowen's outright downgrade today stands apart.
The short-selling data amplifies that caution. Short interest has climbed to 8.4% of the free float, up roughly 66% from a month ago, when it was running near 5%. The week-on-week read shows a 4.2% increase, following a brief dip on Monday. That is a meaningful build for an industrial name: ORTEX's short score has risen to 55.3, climbing steadily from 50.3 two weeks ago. Despite that build, the borrow market remains entirely unthreatening — availability is running at 403%, meaning four shares are available to borrow for every one already short, and cost to borrow is just 0.50%, down from a brief spike last week. There is no squeeze pressure here; shorts are entering at low cost with ample room.
Options tell the opposite story. The put/call ratio has collapsed to 0.15, nearly three standard deviations below its 20-day average of 0.21 — the most call-heavy positioning in at least a year, against a 52-week low of 0.11. That signals options traders are not bracing for downside. Calls are dominating the flow, which sits in stark contrast to the short interest build. The two signals are pulling in different directions: equity traders are rebuilding bearish bets, while options flow remains aggressively long.
The backdrop for that divergence is a stock that has had a complicated few months. FLS rose 15% over the past month to $79.98, recovering sharply from a severe April sell-off. The prior two earnings prints each delivered double-digit negative reactions — the stock fell roughly 13%-15% the day after Q1 results in late April, and fell another 2% following the May update. The bull case rests on impressive margin expansion: adjusted operating margins hit 14.8%, up 370 basis points year-on-year. Bears point to the downward revision in organic sales guidance, now 1%-3%, well below prior expectations, and a stock that trades at a P/E near 19x and EV/EBITDA near 12.5x against a sector that offers limited re-rating room. Peers PH and ITT each fell on Tuesday, down 1.5% and 2.4% respectively, while ESAB slid 5.5% — FLS's 2% decline on the day was in line with the broader group.
Institutional ownership adds one note of interest. BlackRock added roughly 1.5 million shares through May, lifting its stake to 10.3% of shares outstanding. That is a material addition from one of the stock's largest holders, and runs against the grain of the building short position. Two board-level insiders also made open-market purchases in May at prices between $65 and $68 — both now sitting on paper gains — lending a degree of insider conviction below $70 that is relevant context for the TD Cowen target set at that level.
The next date that matters is July 29. With two consecutive earnings sell-offs already on the tape, a short interest at a one-month high, a fresh downgrade, and call-heavy options flow suggesting the market still expects a recovery, the July print will resolve whether the margin story or the guidance cut carries more weight with investors.
See the live data behind this article on ORTEX.
Open FLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
